TIS - EI-Dose
View samplesTemplate
Attributes
| Name | Type | Description | PID  | Unit |
|---|---|---|---|---|
| UID* | Text | Not specified | - | - |
| Name | Text | Not specified | - | - |
| Protocol | URI | Not specified | - | - |
| Scientist | Text | Not specified | - | - |
| SampleCreationDate | Text | Not specified | - | - |
| Parent | Registered Sample - PAV - EI-Dose | Not specified | - | - |
| Type | Text | Not specified | - | - |
| Organ | Text | Not specified | - | - |
| OrganDetail | Text | Not specified | - | - |
| Notes | Text | Not specified | - | - |
| NumVials | Text | Not specified | - | - |
Tags
Not specified Creators and SubmitterViews: 118 Downloads: 2
Created: 19th Dec 2023 at 20:51
Last updated: 19th Dec 2023 at 20:52
TagsThis item has not yet been tagged.
AttributionsNone
Related items
Projects: Hi-IMPAcTB, MIT SRP, MetNet, Endometriosis, Cancer Systems Biology Consortium (CSBC)
Institutions: Massachusetts Institute of Technology
Projects: Hi-IMPAcTB
Web page: https://www.niaid.nih.gov/research/immune-mechanisms-protection-mycobacterium-tuberculosis
About
This project houses all the publicly available datasets generated by the Hi-IMPAcTB consortium over the course of its 7+ years.
What is Hi-IMPAcTB?
Hi-IMPAcTB is an ambitious endeavor bringing together a team of international, interdisciplinary researchers to improve our understanding of host-pathogen interactions in the context of tuberculosis (TB). Funded by a multi-center contract from the NIH, the long-term goal of the consortium is to enable principled vaccine design by improving ...
Programme: IMPAcTB
Public web page: https://grantome.com/grant/NIH/75N93019C00071-0-9999-1
